
BRISTOL MYERS SQUIBB CO
BRISTOL MYERS SQUIBB CO (BMY)
주가
시가총액
다음 일정2026/12/12 - 15iberdomide plus daratumumab and dexamethasone — EXCALIBER-RRMM · Phase 3 dataSEC 공시 ↗
현금
차트 및 이벤트
핵심 임상
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
기술 요약
기술 해석과 근거
상세 기술 해석
기술이 줄 수 있는 이점
대표 파이프라인 적용
임상 진행
예정 임상 일정
그 외 파이프라인
파트너 / 라이선스 아웃
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
승인/상업화
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
Approved
PreINDP1P2P3FilingApproved
과거 이력 · 중단/보류
자금 현황
주식 보유 현황·기관투자자
| 상태 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|